Proxsys Rx

MAY 3, 2023

340B ESP and drug manufacturer restrictions are only part of the reason As we noted in a previous post , for 340B-eligible hospitals dealing with increasingly squeezed bottom lines, an in-house specialty pharmacy offers enormous savings and revenue potential. Novartis is sending a variation of the same letter to hospitals.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Documentation Labelling 52

pharmaphorum

MARCH 3, 2022

The findings – published today in the journal Nature Medicine – come after Jardiance was approved for chronic heart failure with reduced ejection fraction (HFrEF) last year, with the label expanded to include patients with heart failure with preserved ejection fraction (HFpEF) last month. It has been used to treat type 2 diabetes since 2014.

Labelling 98

Labelling Diabetes Hospitals 98

pharmaphorum

SEPTEMBER 16, 2020

The phase 3 open-label trial will test the cocktail in patients hospitalised with COVID-19 and will compare the effects of adding the antibody cocktail REGN-COV2 to the usual standard-of-care versus standard-of-care on its own. The post Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial appeared first on.

Hospitals 98

Hospitals Labelling Immunity Immunization 98

Pharmacy Joe

NOVEMBER 10, 2021

In this episode, I’ll discuss colchicine in patients admitted to hospital with COVID-19. Episode 660: Does colchicine work in patients admitted to hospital with COVID-19? mg orally 12 hours later and twice daily thereafter for 10 days or until hospital discharge. appeared first on Pharmacy Joe.

Hospitals 40

Hospitals Inpatient Dosage Labelling 40

European Pharmaceutical Review

JANUARY 20, 2023

The MHRA’s authorisation is significant “… as there is no targeted treatment currently authorised for MZL patients other than chemoimmunotherapy,” explained Dr Renata Walewska, Department of Hematology, University Hospitals Dorset, Bournemouth, UK.

Labelling 119

Labelling Hospitals 119

RX Note

DECEMBER 25, 2024

Introduction Consumers from private hospitals and clinics are provided with a huge range of brand choices , being it original or generic brand. Off label use information can be found here too. However, some might prefer to use only the brand recommended by their family doctor.

Biosimilars 52

Biosimilars Community Pharmacies Labelling Communication 52

European Pharmaceutical Review

DECEMBER 13, 2024

This authorises a novel CE-labelled needle for intravitreal injection. The European Medicines Agency (EMA) has approved Roche’s Vabysmo (faricimab) prefilled syringe (PFS) as the EUs first and only bispecific antibody prefilled syringe for retinal conditions causing vision loss.

Diabetes 97

Diabetes Labelling Hospitals 97

pharmaphorum

SEPTEMBER 7, 2022

The European Commission has approved Tecartus (brexucabtagene autoleucel) for adults aged 26 and over with relapsed or refractory B-cell precursor ALL, a patient population not covered by the label for Novartis’ CD19 CAR-T Kymriah (tisagenlecleucel), which covers paediatric and young adult patients up to age 25.

Labelling 98

Labelling Chemotherapy Hospitals 98

Pharmacy Joe

AUGUST 16, 2023

By predicting this need in advance, calculating doses, preparing and labeling syringes, the pharmacist can also enhance medication safety and free up the rest of the care team to remain hands-on with the patient ensuring adequate pre-oxygenation, IV access, and supportive care.

Hospitals 98

Hospitals Inpatient Labelling 98

Pharmaceutical Technology

JULY 20, 2022

While the label expansion will likely increase avenues for patients to access the antiviral, Ganio adds one caveat: due to burnout and turnover seen across the healthcare field, including pharmacy staff, there are going to be sites that just don't have the resources to dedicate a pharmacist to do some of this work.

Labelling 111

Labelling Community Pharmacies Medical Records Communication 111

Pharmaceutical Technology

SEPTEMBER 5, 2022

Simpson alleged in a lawsuit filed in the District of New Jersey that Bayer paid kickbacks to physicians and hospitals to prompt them to use Trasylol and Avelox. Simpson also alleged that the company sold these drugs for off-label usages that were not acceptable and essential.

Labelling 105

Labelling Hospitals 105

European Pharmaceutical Review

JULY 27, 2023

Soliris showed “sustained improvements in disease severity of generalised myasthenia gravis through 26 weeks in a Phase III trial,” stated Dr John F Brandsema, Children’s Hospital of Philadelphia and primary investigator in the Phase III trial.

Labelling 98

Labelling Hospitals 98

pharmaphorum

DECEMBER 15, 2022

Boehringer did not carry out a dedicated clinical trial to show the benefit of Ofev in this less severely affected population, but provided subgroup analyses from two earlier studies – INPULSIS and TOMORROW – plus open-label extensions. The post NICE backs use of Boehringer’s Ofev in IPF from diagnosis appeared first on.

Labelling 105

Labelling Hospitals 105

European Pharmaceutical Review

JUNE 10, 2024

New five-year data from Genentech (a member of the Roche Group)’s open-label extension of the pivotal Phase II FIREFISH study confirm the sustained efficacy and safety of Evrysdi ® (risdiplam) in children with Type 1 spinal muscular atrophy (SMA). What did the FIREFISH extension study find?

Labelling 98

Labelling Hospitals 98

European Pharmaceutical Review

DECEMBER 6, 2022

The MAA includes results from the Phase III VALOR study, its open label extension (OLE) study, a Phase I study in healthy volunteers and a Phase I/II study evaluating ascending dose levels of tofersen. Clinical data included in the marketing authorisation application. Biogen licensed tofersen from Ionis Pharmaceuticals, Inc.

Labelling 98

Labelling Hospitals 98

pharmaphorum

OCTOBER 16, 2020

Gilead’s Veklury (remdesivir) has failed to produce an effect on hospital stay and mortality in COVID-19 patients in a large global trial, casting doubt on previous supportive study findings. According to the study the regimens have little or no effect on length of hospital stay or 28-day mortality, the WHO said.

Hospitals 76

Hospitals Labelling Compounding 76

European Pharmaceutical Review

JUNE 28, 2022

The Phase III Asclepios I/II trials and the Alithios open-label extension from Novartis , showed that earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study.

Labelling 98

Labelling Hospitals 98

The Honest Apothecary

APRIL 24, 2023

A condition known as “Opioid Induced Hyperalgesia” or OHA has been reported enough times now that the FDA is requiring an update to all the labeling of all opioids to reflect this potential risk. “After starting to use the new version, the patient experienced 3 seizures, which led to her being admitted to the hospital.

Compounding 97

Compounding Labelling Hospitals 97

RX Note

JULY 2, 2023

Introduction American Hospital Formulary Service Drug Information (AHFS DI) from the American Society of Health-System Pharmacists (ASHP) is a comprehensive source of drug information for health professionals with therapeutic guidelines and off-label uses.

Labelling 40

Labelling Hospitals 40

pharmaphorum

FEBRUARY 3, 2021

But after an initial loading phase it cuts the number of hospital visits required to get the same clinical effect, with a dosing period of up to 12 weeks. More than half of patients were maintained on 12-weekly dosing regimens after the loading phase in a 48-week trial, Novartis pointed out.

Labelling 98

Labelling Hospitals 98

European Pharmaceutical Review

AUGUST 10, 2022

The prospective, open-label, single-arm, Phase II TUXEDO-1 study enrolled 14 women and one man with human epidermal growth factor receptor 2 (HER2)-positive breast cancer and newly diagnosed untreated brain metastases or brain metastases progressing after previous local therapy.

Chemotherapy 98

Chemotherapy Labelling Hospitals 98

European Pharmaceutical Review

DECEMBER 1, 2022

Between 2016 and 2019, DNDi and its partners led an open-label, Phase II/III study to assess the safety and efficacy of acoziborole in patients with early- and late-stage g-HAT. 208 patients were recruited at 10 hospitals in the Democratic Republic of the Congo (DRC) and Guinea. About the Phase II/III study.

Labelling 98

Labelling Hospitals 98

RX Note

MARCH 18, 2023

Also, it forms the hospital/clinical drug formulary foundation for all government healthcare facilities at Malaysia. Not all hospital drugs are listed in MOHMF. Not all drugs in MOHMF are available in our hospital/clinic. Government should initiate a local hospital/clinic drug formulary mobile application instead.

Hospitals 52

Hospitals Dosage Labelling 52

Pharma Pathway

FEBRUARY 14, 2023

Candidates from OSD and Injectibels can attend interview.

People Management 64

People Management Labelling Hospitals 64

European Pharmaceutical Review

NOVEMBER 28, 2022

The comparative, randomised, open-label clinical trial evaluated the drug’s short- and long-term efficacy, safety and tolerability. Patients treated with SPRAVATO ® achieved greater rates of remission at Week eight: 27.1 percent versus 17.6 percent, respectively; p=0.003) compared to those given quetiapine XR.

Labelling 98

Labelling Hospitals 98

Pharmaceutical Technology

JUNE 21, 2023

Ketarx will be marketed under the FDA-approved label of ketamine and in dosages that include 10mg/ml, 50mg/ml and 100mg/ml, with the option to boost the concentration and ready-to-administer applications. PharmaTher and Vitruvias Therapeutics have entered a collaboration deal to commercialise PharmaTher’s Ketarx (racemic ketamine) in the US.

Hospitals 52

Hospitals Dosage Labelling 52

pharmaphorum

OCTOBER 22, 2020

Phase 3 trials are expected to start in Q1 2021, and will test the drug outside of the hospital setting. By joining forces with Atea, we hope to offer an additional treatment option for hospitalised and non-hospitalised COVID-19 patients, and to ease the burden on hospitals during a global pandemic.”

Hospitals 66

Hospitals Biosimilars Labelling 66

pharmaphorum

MAY 31, 2022

The new label means that Evrysdi (risdiplam) can now be used across all ages – from newborns to adults – allowing it to target the same groups as rival therapies Spinraza (nusinersen) from Biogen and Novartis’ one-shot gene therapy Zolgensma (onasemnogene abeparvovec).

Labelling 59

Labelling Hospitals 59

Pharmaceutical Technology

JULY 29, 2022

Off-label medication options. Similar to risperidone and aripiprazole, olanzapine’s administration is limited to oral pills and injections, often in hospital settings. An inability to clearly communicate with others and express their wants and needs results in frustration, he adds.

Communication 105

Communication Labelling Hospitals 105

Pharma Packaging Solutions

AUGUST 18, 2020

Hospital Unit Dose (HUD) Packaging. Vial labeling. Companies may wish to plan now to ensure registrations for a US-based CMO are in place to allow a quick change should it become critical. We can help you with your bottling, blistering and cartoning needs. Low Humidity Packaging (we can hold 3% humidity in 70 degrees Fahrenheit).

Packaging 52

Packaging Labelling Hospitals 52

pharmaphorum

JUNE 6, 2022

Even though some of these “middlemen” are supposed to obtain drugs at a lower price for their clients (ie, insurance companies, pharmacies, hospital systems, et cetera), some argue their fees can cause the end price of prescription drugs to skyrocket. “And, of course, Truepill, who does our prescription fulfilment.”

Drug Pricing 144

Drug Pricing Online Pharmacies Labelling Hospitals 144

pharmaphorum

OCTOBER 23, 2020

The approval is supported by data from two randomised, open-label, multi-centre phase 3 clinical studies of Veklury conducted by Gilead. Earlier this month preliminary results from the World Health Organization’s large Solidarity trial suggested that the drug had failed to produce an effect on hospital stay and mortality.

Hospitals 59

Hospitals Labelling 59

Pharmacy Joe

NOVEMBER 26, 2023

Provide infusions to the nurse in the most ready-to-use form possible including obtaining the smart pump, IV tubing, spiking the bag and priming the tubing, and labeling the lines. To get immediate access, go to pharmacyjoe.com/academy.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

NOVEMBER 26, 2023

Provide infusions to the nurse in the most ready-to-use form possible including obtaining the smart pump, IV tubing, spiking the bag and priming the tubing, and labeling the lines. To get immediate access, go to pharmacyjoe.com/academy.

Hospitals 52

Hospitals Inpatient Labelling 52

Pharmacy Joe

SEPTEMBER 3, 2023

Shout out to “Pulmonology Tony” and Hospital Pharmacy Academy members “Pharmacy David” and “Pharmacy Sally” for inspiring this episode. In this episode, I’ll discuss whether apixaban’s loading dose duration should ever be shortened.

Labelling 52

Labelling Hospitals Inpatient 52

Pharmacy Joe

SEPTEMBER 3, 2023

Shout out to “Pulmonology Tony” and Hospital Pharmacy Academy members “Pharmacy David” and “Pharmacy Sally” for inspiring this episode. In this episode, I’ll discuss whether apixaban’s loading dose duration should ever be shortened.

Labelling 52

Labelling Hospitals Inpatient 52

Pharmaceutical Technology

SEPTEMBER 5, 2022

Wholesalers can be either full-line wholesalers, who purchase the complete product line of a company, or specialised companies, which purchase speciality drugs to sell to clinics and hospitals. Some of the major factors considered in the selection of a wholesaler include: · Cost that includes product type, payment terms, and delivery cost.

Documentation 52

Documentation Packaging Labelling Pharmaceutical Manufacturing 52